Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Amyotrophic Lateral Sclerosis (ALS) Clinical Trials

102 recruiting trials for Amyotrophic Lateral Sclerosis (ALS). Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
102
Total Trials
102
Recruiting Now
3
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGNCT05635266

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

To collect, preserve, and/or distribute annotated biospecimens and associated medical data to institutionally approved, investigator-directed biomedical research to discover and...

Sponsor: Sanguine BiosciencesEnrolling: 200001 location
RECRUITINGNCT07460037

Chinese-Specific Speech Imagery Coding Using High-Density ECoG

The goal of this study is to investigate whether high-density electrocorticography (ECoG) signals recorded from the surface of the brain can be used to decode neural...

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang UniversityEnrolling: 501 location
RECRUITINGNCT06377033

Using the EHR to Advance Genomic Medicine Across a Diverse Health System

Given the expansion of indications for genetic testing and our understanding of conditions for which the results change medical management, it is imperative to consider novel ways...

Sponsor: University of PennsylvaniaEnrolling: 10001 location
RECRUITINGNCT07257302

Lung Insufflation Capacity Training and Respiratory Function in Amyotrophic Lateral Sclerosis

The goal of this clinical trial is to learn whether lung insufflation capacity (LIC) training can help maintain respiratory function and prolong survival in people with...

Sponsor: National Center of Neurology and Psychiatry, JapanEnrolling: 151 location
RECRUITINGNCT07358741

Standard Two-Day Advanced Life Support (ALS) Versus One Day Recertification Course

this study aims to compare the effectiveness of a one-day versus two-day ALS recertification course in terms of knowledge retention, practical skills performance, participant...

Sponsor: National Hepatology & Tropical Medicine Research InstituteEnrolling: 1581 location
RECRUITINGNCT05724173

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia

The purpose of this study is to obtain preliminary device safety information and demonstrate proof of principle (feasibility) of the ability of people with tetraplegia to control...

Sponsor: Leigh R. Hochberg, MD, PhD.Enrolling: 32 locations
RECRUITINGNCT07224256

VOICE: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for Communication...

The VOICE Study is an early feasibility study to evaluate the initial clinical safety and efficacy of the N1 and R1 Systems device design concept in providing an ability to...

Sponsor: Neuralink CorpEnrolling: 61 location
RECRUITINGNCT05119387

Genetic Study of Amyotrophic Lateral Sclerosis in Norway

The purpose of this study is to explore the genetic causes relevant for ALS development in Norway.

Sponsor: Sykehuset TelemarkEnrolling: 120017 locations
RECRUITINGNCT05852418

Registry Study of Assistive Devices, Medicines and Healthcare Measures in ALS, SMA and Other Neurological Diseases.

This registry study aims to collect data on the provision of assistive devices, medicines, and other healthcare measures, such as ventilation therapy and nutrition support, in...

Sponsor: Ambulanzpartner Soziotechnologie APST GmbHEnrolling: 2500016 locations
RECRUITINGNCT06318585

Creation of a Clinical Database for the Study of Phenotypic Variability in Motor Neuron Diseases

Study Description: Characterization of Motor Neuron Disease Phenotypes The goal of this observational study is to understand the clinical presentation of motor neuron disease...

Sponsor: Istituto Auxologico ItalianoEnrolling: 2001 location
RECRUITINGNCT03217396

Biomarkers of Synaptic Damage in Multiple Sclerosis

A prospective and retrospective cohort study of about five years will be performed on blood and cerebrospinal fluid samples taken for diagnostic reasons from recruited patients...

Sponsor: Neuromed IRCCSEnrolling: 3001 location
RECRUITINGNCT07154394

Cardiac Amyloid Deposits and Heart Dysfunction in Alzheimer's Disease

This study seeks to explore the possible common pathogenesis of both cardiac amyloidosis and Alzheimer's disease, which can both be associated with amyloid deposits. Using...

Sponsor: University Hospital, EssenEnrolling: 151 location
RECRUITINGNCT06491732

EIM Via the Myolex mScan as an ALS Biomarker

Amyotrophic lateral sclerosis (ALS) has been traditionally considered incurable and untreatable. But starting in the 1990s with the introduction of Riluzole, therapies are being...

Sponsor: Beth Israel Deaconess Medical CenterEnrolling: 801 location
RECRUITINGNCT06881979

High-Tech Rehabilitation Pathway for Chronic Adult Neuromuscular Diseases - Fit4MedRob-Chronic MND Project

The primary objective is to demonstrate, in a population of chronic neuromuscular disease the non-inferiority of a rehabilitation treatment integrated with robotic and/or...

Sponsor: Istituti Clinici Scientifici Maugeri SpAEnrolling: 607 locations
RECRUITINGNCT05819931

Breathing with Amyotrophic Lateral Sclerosis

The study aims to evaluate the effect of mechanical insufflator-exsufflator on the respiratory functions of Amyotrophic Lateral Sclerosis (ALS) patients evaluated via peak...

Sponsor: University Hospital, ToulouseEnrolling: 361 location
RECRUITINGNCT07502677

Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral...

The specific aim of this study is to try to discover the diagnostic accuracy of SleepImage technology for detecting respiratory failure in patients with MND. Importantly, this...

Sponsor: Royal Brompton & Harefield NHS Foundation TrustEnrolling: 151 location
RECRUITINGPhase 1 / Phase 2NCT06351592

First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation...

This study is researching an experimental drug called ALN-SOD (called "study drug"). This study is focused on people with Amyotrophic Lateral Sclerosis (ALS) caused by a change in...

Sponsor: Regeneron PharmaceuticalsEnrolling: 4216 locations
RECRUITINGNCT06992596

UAE-PRIME: A Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External...

The UAE-PRIME Study is a feasibility study designed to assess the initial clinical safety and functionality of the Neuralink N1 Implant and R1 Robot. This study involves...

Sponsor: Neuralink CorpEnrolling: 101 location
RECRUITINGNCT06877143

Hypercaloric PEG Nutrition in ALS to Sustain Energy Homeostasis

Weight loss is a known negative prognostic factor in amyotrophic lateral sclerosis (ALS). Over the last years, various interventional studies targeting the energy deficit in ALS...

Sponsor: University of UlmEnrolling: 761 location
RECRUITINGPhase 3NCT06008249

Platform Trial to Assess the Efficacy of Multiple Drugs in Amyotrophic Lateral Sclerosis (ALS)

The objective of this phase III, placebo-controlled platform study is to investigate the efficacy of drugs for patients with ALS (Amyotrophic lateral sclerosis).

Sponsor: Stichting TRICALS FoundationEnrolling: 17113 locations
RECRUITINGNCT03865420

Amyotrophic Lateral Sclerosis (ALS) Families Project

This program provides family members of individuals with familial ALS the opportunity to contribute to research focused on learning more about why motor neuron degeneration begins...

Sponsor: Columbia UniversityEnrolling: 3001 location
RECRUITINGNCT03489278

Clinical Procedures to Support Research in ALS

The purpose of the Clinical Procedures To Support Research (CAPTURE) study is to utilize information collected in the medical record to learn more about a disease called...

Sponsor: University of MiamiEnrolling: 120011 locations
RECRUITINGNCT07202494

Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience...

The MESO7 study is a prospective observational research project designed to investigate the mechanisms of resilience and neurodegeneration in neurological diseases and healthy...

Sponsor: Assistance Publique Hopitaux De MarseilleEnrolling: 7001 location
RECRUITINGNCT07213440

Identification of Early Markers for ALS

Although several molecules have been proposed as biomarker candidates, a clinically established signature for an early or even premotor diagnosis of ALS is not available. Due to...

Sponsor: Institut National de la Santé Et de la Recherche Médicale, FranceEnrolling: 601 location
RECRUITINGNCT02869048

Amyotrophic Lateral Sclerosis and the Innate Immune System

Amyotrophic Lateral Sclerosis (ALS) is an aggressive, deadly disease. ALS leads to destruction of the neural pathways which control the conscious movements of the muscles. This...

Sponsor: Rigshospitalet, DenmarkEnrolling: 3758 locations
RECRUITINGNCT07187388

Investigating the Impact of Electrical Stimulation on Facial Pain, Jaw Movement and Oral Health in People With Motor...

The goal of this clinical trial is to evaluate the impact of non-invasive electrical stimulation, when placed on the facial muscles can reduce facial pain and improve jaw...

Sponsor: Nova Southeastern UniversityEnrolling: 101 location
RECRUITINGNCT06844370

Home Versus Hospital Based NIV Care in MND

Non-invasive ventilation (NIV) is commonly offered to people with Motor Neurone Disease (MND) who have breathing difficulties. It improves their quality of life and can prolong...

Sponsor: Papworth Hospital NHS Foundation TrustEnrolling: 601 location
RECRUITINGNCT00874783

Development of IPS from Donated Somatic Cells of Patients with Neurological Diseases

Human fibroblasts and possibly other human somatic cells may be reprogrammed into induced pluripotent stem (iPS) cells by the forced expression of transcription factors (1-5). The...

Sponsor: Hadassah Medical OrganizationEnrolling: 1201 location
RECRUITINGNCT06051123

Effects of Probiotics in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Spectrum Disorder (ALS-FTDSD) Patients

The aim of this study is to assess the impact of a probiotic formulation on participants with ALS-FTDSD. It is hypothesized that participants given the probiotics will have...

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)Enrolling: 1501 location
RECRUITINGNCT05370079

Control Cohort CTRL COH

Autoimmune encephalitis (AE) and paraneoplastic neurological syndromes (PNS) are rare disease that could be difficult to diagnose. So it necessary to obtain numerous sample from...

Sponsor: Hospices Civils de LyonEnrolling: 3501 location
RECRUITINGNCT06551649

Human Amniotic Mesenchymal Cell Secretome for Neurodegeneration and Neuroinflammation

Neurodegenerative diseases are debilitating conditions characterized by chronic inflammation, leading to dysfunction of both the non-neuronal cellular components of the central...

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCSEnrolling: 602 locations
RECRUITINGNCT06249412

The Importance of Positive Expiratory Pressure Associated With the In-exsufflator in ALS Patients

Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disorder that impairs motor neurons, with a life expectancy of 2 to 7 years after diagnosis. ALS manifests as...

Sponsor: Groupe Hospitalier du HavreEnrolling: 111 location
RECRUITINGNCT07175935

Amyotrophic Lateral Sclerosis Registry in Thailand

This is a prospective, observational, multicenter registry designed to collect comprehensive clinical, genetic, and outcome data from patients diagnosed with amyotrophic lateral...

Sponsor: Chulalongkorn UniversityEnrolling: 1001 location
RECRUITINGPhase 2NCT07002034

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

The purpose of this study is to determine if treatment with a single dose of RE104 for Injection reduces depressive symptoms or depressive symptoms mixed with anxiety symptoms in...

Sponsor: Reunion Neuroscience IncEnrolling: 10020 locations
RECRUITINGNCT07067229

Non-invasive Brain Stimulation and Exercise Intervention for Patients With Motor Neuron Disease

Motor neuron disease (MND) is a progressive neurological disorder involving degeneration of motor neurons, leading to muscle weakness, speech and swallowing difficulties, and...

Sponsor: Chulalongkorn UniversityEnrolling: 1001 location
RECRUITINGNCT06280079

Ultra-high-caloric, Fatty Diet in ALS

This study aims at evaluating efficacy and tolerability of an ultra-high-caloric, fatty diet (UFD) compared to placebo in patients with amyotrophic lateral sclerosis (ALS).

Sponsor: University of UlmEnrolling: 39220 locations
RECRUITINGNCT06418646

Patients' and Caregivers' Views of Multidimensional Care in Amyotropic Lateral Sclerosis in Germany

The progressive loss of physical functioning resulting from ALS leads also to high psychosocial burden for those affected, and organizational challenges related to medical care...

Sponsor: Technische Universität DresdenEnrolling: 5001 location
RECRUITINGNCT06810219

Augmented Reality BCI Longitudinal Study for Persons With Late Stage ALS

The goal of this study is refine the usability of a BCI based communication platform. The study will take place in the greater Los Angeles area and will enroll up to 10...

Sponsor: CognixionEnrolling: 101 location
RECRUITINGNCT07341984

A Physiotherapy Intervention Study in Patients With Amyotrophic Lateral Sclerosis (ALS)

This study investigates whether an individualized physiotherapy program, tailored to each patient's specific motor deficits, can better support physical function compared with...

Sponsor: Charlotte VogtEnrolling: 381 location
RECRUITINGNCT06361706

VR-Enhanced Psychoeducation for Chronic Pain: A Primary Care Pilot Study

This pilot study aims to evaluate the integration of virtual reality (VR) with a psychoeducational program for individuals experiencing chronic pain and central sensitization....

Sponsor: Badalona Serveis AssistencialsEnrolling: 604 locations
RECRUITINGNCT06511934

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Tablet-01)

People with brainstem stroke, advanced amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig's disease), or other disorders can become unable to move or speak despite being...

Sponsor: Leigh R. Hochberg, MD, PhD.Enrolling: 21 location
RECRUITINGNCT07357428

Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)

The Connect-One Study is an early feasibility study to obtain preliminary device safety information for the Connexus Brain-Computer Interface (BCI). The Connexus BCI is intended...

Sponsor: ParadromicsEnrolling: 21 location
RECRUITINGNCT00912041

BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia

The purpose of this study is to obtain preliminary device safety information and demonstrate proof of principle (feasibility) of the ability of people with tetraplegia to control...

Sponsor: Leigh R. Hochberg, MD, PhD.Enrolling: 275 locations
RECRUITINGNCT04820478

Efficacy and Tolerability of Beta Hydroxybutyrate Ester in Patients With Amyotrophic Lateral Sclerosis (ALS)

Weight loss is a known negative prognostic factor in amyotrophic lateral sclerosis (ALS). One potential mechanism of weight loss in ALS is a disturbance of the mitochondrial...

Sponsor: University of UlmEnrolling: 761 location
RECRUITINGNCT03225144

Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

Background: Neurodegenerative disorders can lead to problems in movement or memory. Some can cause abnormal proteins to build up in brain cells. Researchers want to understand...

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)Enrolling: 3601 location
RECRUITINGNCT07006571

At-home Treatment With Cortico-spinal tDCS for Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS) is a progressive neurological disease that causes gradual muscle weakness and loss of muscle mass. It affects all muscles that control...

Sponsor: University of TriesteEnrolling: 401 location
RECRUITINGNCT04868994

Magnetic Imaging for Diagnostic of Amyotrophic Lateral Sclerosis

Nearly 60% of Amyotrophic Lateral Sclerosis (ALS) patients have a low level of diagnostic certainty (possible, probable) at the time of diagnosis. In the absence of biomarkers,...

Sponsor: University Hospital, ToulouseEnrolling: 501 location
RECRUITINGEarly Phase 1NCT06656702

Effects of Psilocybin in Patients With Amyotrophic Lateral Sclerosis

This study aims to study the feasibility of psilocybin therapy for patients with Amyotropic Lateral Sclerosis (ALS) with depressed mood. The secondary objective is to assess its...

Sponsor: Johns Hopkins UniversityEnrolling: 241 location
RECRUITINGNCT06228001

Holter of Movement in Patients With Amyotrophic Lateral Sclerosis.

ActiALS is a multicentric academic study. Patients with amyotrophic lateral sclerosis (ALS) may be included on a voluntary basis. The investigators plan to include a group of...

Sponsor: Centre Hospitalier Universitaire de LiegeEnrolling: 303 locations
RECRUITINGNCT05562960

Plasmapheresis in Amyotrophic Lateral Sclerosis With Autoantibody Against NRIP

Patient with amyotrophic lateral sclerosis (ALS) having anti-NRIP autoantibody showed titer-dependent detrimental Effects. Plasmapheresis might benefit this subgroup of patients...

Sponsor: National Taiwan University HospitalEnrolling: 201 location

Showing 50 of 102 trials.Search all Amyotrophic Lateral Sclerosis (ALS) trials